RecruitingPhase 3

Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Egypt80 participantsStarted 2018-12-01

Plain-language summary

Norfloxacin versus Norfloxacin with Itopride in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * cirrhotic patients with ascites who had previous episodes of SBP. Exclusion Criteria: * 1\. Allergy or contraindication for the used drugs. 2. Recent antibiotics therapy in the previous 2 weeks. 3. Patients with hepatocellular carcinoma or other neoplasia. 4. Pregnant and lactating women.

What they're measuring

Number of bouts of recurrence during treatment.

Timeframe: 6 months

Trial details

NCT IDNCT04161768

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2028-12-01

Contact for this trial

Sherief Abd-Elsalam, ass. prof.

00201147773440 sheriefabdelsalam@yahoo.com

View on ClinicalTrials.gov More Spontaneous Bacterial Peritonitis trials